Overview

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD

Status:
Not yet recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
This open-label fMRI study will assess the effects of a single dose of psilocybin on rumination and the neural correlates of rumination in individuals with treatment-resistant major depressive disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
COMPASS Pathways
Treatments:
Psilocybin